文献速递头颈PETCT

新诊断鼻咽癌患者M分期是否需要全身18F-FDG PET/CT

Whole-body 18F-FDG PET/CT for M staging in the patient with newly diagnosed nasopharyngeal carcinoma: Who needs?
PubMed 文献 · Eur J Radiol · 2017-02-09

回顾性分析264例新诊断鼻咽癌患者的全身18F-FDG PET/CT结果与临床数据,仅37例(14.0%)诊断远处转移。多因素logistic回归显示EBV阳性(OR=13.1)、N分期(OR=3.05)和T分期(OR=2.16)与远处转移显著相关;EBV DNA≥9000拷贝/ml、N3期和T4期为高危因素,仅中高危患者需行全身PET/CT进行M分期。

要点

  • 264例新诊断鼻咽癌中仅37例(14.0%)检出远处转移。
  • EBV阳性(OR=13.1)、N分期(OR=3.05)、T分期(OR=2.16)与远处转移显著相关。
  • EBV DNA≥9000拷贝/ml、N3期、T4期为远处转移高危因素。

核心结论

  • 因远处转移发生率低,仅中危或高危风险的患者需要行全身18F-FDG PET/CT进行M分期。

研究设计与样本

  • 回顾性分析264例新诊断鼻咽癌患者的全身18F-FDG PET/CT结果及临床资料,分析年龄、性别、病理类型、病灶大小、SUVmax-T、T分期、N分期、SUVmax-N和EBV数量与远处转移的关系。

关键影像表现/征象

  • 全身18F-FDG PET/CT用于新诊断鼻咽癌的M分期,264例中37例(14.0%)诊断为远处转移。

诊断标准与关键数值

  • 多因素logistic回归:EBV阳性与远处转移相关(OR=13.1;95%CI:1.61,106.80)。
  • 多因素logistic回归:N分期与远处转移相关(OR=3.05;95%CI:1.41,6.63)。
  • 多因素logistic回归:T分期与远处转移相关(OR=2.16;95%CI:1.10,4.24)。
  • EBV DNA≥9000拷贝/ml、N3期和T4期被确定为高危因素。
  • 0-1个危险因素及2个特定危险因素(T3/T4和N2/N3)的患者远处转移风险低;EBV DNA≥9000拷贝/ml且N3或T4期及3个危险因素的患者为中危或高危,远处转移发生率更高(χ2=29.896,P=0.000),需行全身18F-FDG PET/CT进行M分期。

临床应用与阅片要点

  • 作者认为,因远处转移发生率低,仅中危或高危风险患者需要行全身18F-FDG PET/CT扫描进行M分期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Although whole-body fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) (18F-FDG PET/CT) is commonly used for M staging of newly diagnosed nasopharyngeal carcinoma (NPC), some patients may not benefit from this procedure. The present study investigated which patients require this modality for M staging.

METHODS: Whole-body 18F FDG PET/CT results and clinical data were collected for 264 patients with newly diagnosed NPC. The relationships between distant metastasis and age, gender, pathological type, lesion size, SUVmax-T, T staging, N staging, SUVmax-N and Epstein-Barr virus (EBV) quantity were retrospectively analysed to identify factors associated with increased risk.

RESULTS: Of the 264 patients, only 37 (14.0%) were diagnosed with distant metastasis. Using multiple logistic regression analysis, EBV-positivity (OR=13.1; 95% CI:1.61,106.80), N staging (OR=3.05; 95% CI:1.41,6.63) and T staging (OR=2.16; 95% CI:1.10, 4.24) were significantly related to distant metastasis (all P<0.05). EBV DNA levels≥9000copies/ml, N3 stage and T4 stage were identified as high risk factors. A low risk of distant metastasis was found in patients with 0-1 risk factors and in those with 2 specific risk factors, T3/T4 and N2/N3 staging. Patients with EBV DNA levels ≥9000copies/ml and N3 or T4 staging and those with 3 risk factors had a medium or high risk, with a much higher incidence of distant metastasis (χ2=29.896, P=0.000), and needed a whole-body 18F FDG PET/CT for M staging.

CONCLUSIONS: Due to the low incidence of distant metastasis, only patients with medium or high risk need to undergo a whole-body scan.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ren YY, Li YC, Wu HB, et al. Whole-body 18F-FDG PET/CT for M staging in the patient with newly diagnosed nasopharyngeal carcinoma: Who needs? Eur J Radiol. 2017. PMID: 28267540. doi:10.1016/j.ejrad.2017.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。